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The names of Thomas Eiwegger, Julia Upton, Gordon Sussman and Thomas Poder were inadvertently omitted from the authorship of the original article \[[@CR1]\]. Thomas Eiwegger, Julia Upton, Gordon Sussman and Thomas Poder had participated in meetings and exchanges regarding the trial design and their names are added to recognise their contribution to the conception of the protocol.

The full and correct authorship has been updated in the original article and included in the author list of this Correction article.

The 'Competing interests' section is also corrected here to read: The authors declare no conflict of interest related to the study. KS reports personal fees from Novartis outside the submitted work. TE reports grants from DBV technologies, Innovation fund Denmark, CIHR, and Regeneron and personal fees from ALK ourside the submitted work. He serves as associate editor for Allergy. JU reports personal fees from Food Allergy Canada, ALK-Abelló, Kaleo, and grants from Toronto SickKids Foundation, DBV technologies, Regeneron, and ALK-Abelló outside the submitted work. GS reports personal fees from Novartis, Aralez, CSL Behring, Sanofi, Pediapharm, GSK, Genentech, DBV technologies, Aimmune, Astrazeneca, Stallergenes, Merck, Pfizer, Dyax, Biocryst, Greencross, Kendrion, Shire, Leopharma, Regeneron, mdBriefCase and grants from Novartis, GSK, Genentech, DBV technologies, Aimmune, CSL Behring, Astrazeneca, Stallergenes, Merck, Pfizer, Dyax, Biocryst, Greencross, Kendrion, Leo Pharma, Regeneron, Sanofi, Blueprint, ALK, Amgen, Cliantha outside the submitted work. ADR reports grants from Merk and ALK outside the submitted work. PB reports personal fees from Novartis, Pfizer, Sanofi, ALK and Aralez, as well as grants from DBV technologies, Regeneron and Sanofi outside the submitted work.
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